21 May 2009
Concentration of anti-7-ketocholesterol antibodies in serum from patients after heart transplantation
T Wielkoszyński, M Szewczyk, M ZembalaAnn Transplant 2009; 14(1): 31-31 :: ID: 880310
Abstract
Oxidized LDL have been shown to be strongly atherogenic and immunogenic in experimental animals and in humans. Similarly, autoantibodies against ox-LDL and various epitopes of ox-LDL have been detected in sera and atherosclerotic lesions. Those autoantibodies are mainly directed against adducts of lipid peroxidation products (mainly highly reactive carbonyls) and apolipoproteins or aminolipids. Oxidation of LDL may also lead to generation of oxidized derivatives of cholesterol (i.e. 7-ketocholesterol - 7-ketoCh), which are characterized by high cytotoxicity, muta- and carcinogenicity as well as
immunosuppressive effect and probably immunogenic properties. The aim of this study was quantification of autoantibodies to 7-ketoCh in sera from patients post OHT. Antibodies in IgG class were measured in sera from 81 patients post OHT and 73 healthy volunteers with the use of home-made ELISA method. As antigen we used 7-ketoCh hemisuccinate conjugated to bovine serum albumin. Anti-7-ketoCh antibodies were detected in all examined sera. Their concentration was significantly higher in OHT patients than in control groups (respectively 109.0±109.7 and 53.5±20.0 U/ml, p<0.005). Also relationship between antibodies concentration and time between OHT and sampling was observed. The obtained results show that also low molecular products of LDL oxidation - 7-ketoCh are immunogenic and probably anti-7-ketoCh autoantibodies can play a role in progression of atherosclerosis in OHT patients.
Keywords: Heart Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860